Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success

On 12 November, Lonza will host a free 60-minute webinar during which Nephron Pharmaceuticals will explain its decision to take a paperless approach to batch record management. Nephron will also discuss how its close relationship with Lonza allowed for a rapid implementation of Lonza's MODA-ES™ Electronic Batch Record (EBR) Platform in just nine months, leading to increased operational efficiency and expanded product lines.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Recording batch data is an essential part of the pharmaceutical manufacturing process. However, the wealth of information generated by each batch is traditionally collected using paper-based workflows, which are inherently resource intensive, time consuming and can negatively impact the time-to-market for new therapeutics. As such, pharmaceutical manufacturers are increasingly turning to paperless EBR solutions to eliminate these challenges.

In the webinar titled “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success,” Bryan Beck, Vice President for Automation and Information Technology at Nephron Pharmaceuticals, will discuss the following topics:

· Why Nephron implemented an EBR Platform

· How the collaborative approach to expedited implementation resulted in an EBR Platform with a user-friendly and configurable design

· How the implementation of Lonza’s MODA-ES™ EBR Platform at Nephron has enabled compliance with regulatory requirements while driving growth and operational efficiency

Paper to EBR in 9 Months: How a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo